Stocks · News reference
Biodexa Says 87 Of Planned 168 Subjects Recruited In Registrational Phase 3 Serenta Trial Of eRapa In Familial Adenomatous Polyposis
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Biodexa Pharmaceuticals Announces Warrant Exercise Agreement For 2,204,218 ADSs At $1.05 For About $2.3M Gross Proceeds; Issues New Five-Year Warrants For Up To 4,408,436 ADSs At $1.05
Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket
Veea shares surged 58% premarket on a NovaGen merger plan and $10M GeoNova investment, while other stocks posted notable gains and losses.
Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures fell, with Nasdaq 100 futures down 500 points. Corning dropped 8% after a $2B offering; several other stocks also slid premarket.